NCT07293468 2026-04-09
BIIRTH
Tuen Mun Hospital
Phase 2/3 Recruiting
Clinical Trials
71 trialsNCT07166406 2026-04-08
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
NRG Oncology
Phase 3 Recruiting
NCT07075120 2026-03-31
Ipilimumab and Nivolumab With SBRT in Locally Advanced Hepatocellular Cancer
University of Hawaii
Phase 1 Not yet recruiting
NCT01165346 2026-03-13
CKNO-HEP
Centre Oscar Lambret
Phase 2 Completed
NCT04785287 2026-03-03
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
Phase 1/2 Terminated
NCT06218420 2026-03-03
TRANSRAD-01
Assistance Publique - Hôpitaux de Paris
Phase 2 Recruiting
NCT05488522 2026-02-20
SBRT With Atezo/Bev for HCC
Abramson Cancer Center at Penn Medicine
Phase 1 Recruiting
NCT07407257 2026-02-18
SBRT for Liver Tumors, Liver Metastases, and Pancreatic Tumors
Institute of Oncology Ljubljana
Phase NA Completed
NCT07381660 2026-02-02
SBRT Versus Surgical Resection for Small HCC
Sun Yat-sen University
Phase 3 Not yet recruiting
NCT01730937 2026-01-28
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
Radiation Therapy Oncology Group
Phase 3 Completed
NCT07305428 2025-12-26
Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study
The University of Hong Kong
Phase NA Recruiting
NCT03316872 2025-07-25
Study of Pembrolizumab and Radiotherapy in Liver Cancer
University Health Network, Toronto
Phase 2 Terminated
NCT03895359 2025-03-11
TACE
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Recruiting
NCT03812289 2025-03-07
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
NCT05596630 2025-02-10
Stereotactic Body Radiation Therapy for the Safety and Prognosis of Small Intrahepatic Recurrent HCC
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Recruiting
NCT06766643 2025-01-09
Stereotactic Radiosurgery Versus Radiofrequency Ablation for Primary Liver Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06725121 2024-12-16
MacroTrans
University Health Network, Toronto
Phase 1/2 Recruiting
NCT06313190 2024-11-18
HSBRT2402
Sun Yat-sen University
Phase 2 Recruiting
NCT00607828 2024-11-04
Stereotactic Radiation Therapy in Treating Patients With Advanced Liver Cancer
University of Nebraska
Phase NA Completed
NCT06664996 2024-10-30
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
West China Hospital
Phase 2 Recruiting
NCT06592612 2024-09-19
Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment
Sun Yat-sen University
Phase 2 Not yet recruiting
NCT03960008 2024-08-28
SBRTvsTACE
Lahey Clinic
Phase 3 Terminated
NCT04047173 2024-06-17
RFA Versus SBRT for Recurrent Small HCC
Sun Yat-sen University
Phase 3 Completed
NCT02762266 2024-03-12
Transarterial Chemoembolization Compared With Stereotactic Body Radiation Therapy or Stereotactic Ablative Radiation Therapy in Treating Patients With Residual or Recurrent Liver Cancer Undergone Initial Transarterial Chemoembolization
Stanford University
Phase 3 Terminated
NCT06261125 2024-03-12
HSBRT2401
Sun Yat-sen University
Phase 2 Recruiting
NCT02182687 2024-03-05
SBRTvsTACE
Lahey Clinic
Phase 2 Completed
NCT05185531 2024-01-05
Notable-HCC
Shandong Cancer Hospital and Institute
Phase 1 Unknown
NCT01910909 2023-11-22
SBRT for HCC
Samsung Medical Center
Phase NA Completed
NCT04235660 2023-10-25
SBRT vs Y90
Indiana University
Phase NA Terminated
NCT06040177 2023-09-15
Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
First Affiliated Hospital of Guangxi Medical University
Phase 1/2 Unknown
NCT05433701 2023-08-18
Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC
Asan Medical Center
Phase NA Active not recruiting
NCT02513199 2023-06-18
Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma
Icahn School of Medicine at Mount Sinai
Phase 2 Completed
NCT05157451 2023-03-23
Y-90 Versus SBRT for Inoperable HCC
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT02683200 2023-02-21
MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT05602974 2023-02-17
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase NA Not yet recruiting
NCT04387695 2023-02-16
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
First Affiliated Hospital of Zhejiang University
Phase 3 Unknown
NCT01899261 2022-11-29
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Albert Einstein College of Medicine
Phase NA Completed
NCT02507765 2021-10-13
Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT00914355 2021-10-06
Stereotactic Body Radiation Therapy (SBRT) Hepatocellular Carcinoma (COLD 2)
University Health Network, Toronto
Phase 2 Completed
NCT04891874 2021-09-10
Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVI
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT02921139 2021-08-30
TASABR
Dalin Tzu Chi General Hospital
Phase NA Unknown
NCT04913480 2021-06-04
SBRT and Durvalumab for Inoperable/Unresectable Hepatocellular Carcinoma
The University of Hong Kong
Phase 2 Unknown
NCT04167293 2021-03-23
ISBRT01
Sun Yat-sen University
Phase 2/3 Unknown
NCT03898921 2020-11-24
RFA vs. SBRT for Small HCC
Sun Yat-sen University
Phase 3 Unknown
NCT03172559 2020-08-20
RADBRI
University Health Network, Toronto
Phase NA Withdrawn
NCT04434989 2020-06-17
SAIL
Sun Yat-sen University
Phase NA Unknown
NCT02989870 2020-06-05
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT01347333 2020-03-03
Stereotactic Body Radiotherapy for Liver Tumors
Mercy Research
Phase NA Completed
NCT04202523 2019-12-17
Combined Radiotherapy and Radiofrequency Ablation for Hepatocellular Carcinoma
Guangxi Medical University
Phase 3 Unknown
NCT04169399 2019-11-19
Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT
Sun Yat-sen University
Phase 2 Unknown